Category

News

£800,000 for Quotient

Diabetes testing technology developer Quotient Diagnostics has raised £800,000 from a syndicate of backers - including The Capital Fund, GEIF Ventures and NESTA - and will use the cash to develop its technologies through to commercialisation.

News

News

Cash shells: the clock ticks

Looking for a quick route to the stock market with a tidy sum of cash thrown in for good measure? Then why not take the cash shell route. There are 88 shells on AIM, with £77.1 million in cash between them - and most of it has to be spent in the next eight months.

News

AIM’s best advisers

For companies eyeing flotation, perhaps the greatest headache is securing a team of advisers to guide you through the IPO process. Fortunately, the level of expertise available remains reassuringly high, as this year’s Growth Company Awards prove.

News

Growing firms urged to report competitors

Anti-competitive practices are damaging the UK's growing businesses and the Office of Fair Trading is calling for them to fight back.

News

Pensions group eyes float

Phoenix Private Equity plans to put £14 million into demutualising the Pension Annuity Friendly Society ahead of an eventual share float or trade sale.

News

Pivotal deal for NVM

Pivotal Laboratories, a Yorkshire-based business that conducts clinical trials for pharmaceutical and biotech firms, has completed a multi-million-pound management buyout with the aid of Northern Venture Managers (NVM).

News

Helphire snaps up Swift

As foreshadowed here, accident management specialist Helphire has agreed to buy private upmarket car hire company Swift Rentacar for up to £25.2 million in shares and paper.

News

Roche snaps up Glycart

Pharmaceutical giant Roche has boosted returns significantly at technology fund manager Quester by taking over portfolio company GlycArt for £104 million.

News

Helphire snaps up Swift

As foreshadowed here, accident management specialist Helphire has agreed to buy private upmarket car hire company Swift Rentacar for up to £25.2 million in shares and paper.

News

Roche snaps up Glycart

Pharmaceutical giant Roche has boosted returns significantly at technology fund manager Quester by taking over portfolio company GlycArt for £104 million.

News

Karibian cruises to AIM

American entrepreneur George Karibian, who has already built up one £47 million telecoms business in Europe, hopes to stage a repeat performance in Britain in the traditionally prosaic field of office equipment.

News

Strathdon sparks Oxsensis’ potential

Oxsensis, an Oxford-based company specialising in advanced instrumentation systems for gas turbines, has secured £890,000 of early-stage funding from backers including AIM-listed Strathdon Investments.

News

3i sells UbiNetics to CSR

Global venture capital group 3i has announced the sale of its stake in Cambridge-based UbiNetics for $48 million (£27.3 million), representing an 80 per cent return on investment in just 18 months.

News

AIM launch for ubet2win

Acquisitive bookmaking group ubet2win, which has pitches at courses in England and Ireland and is advised by Beaumont Cornish, is introducing its shares onto AIM tomorrow at 3.5p.